All articles tagged: Other osteoporosis without current pathological fracture (M81.8)
![]()
HealthDay
30 January at 03.55 PM
Heavy Metals May Diminish Ovarian Reserve for Women Approaching MenopauseFor women approaching the final menstrual period (FMP), heavy metals may diminish ovarian reserve, according to a study published online Jan. 25 in the Journal of Clinical Endocrinology & Metabolism.Ning Ding, Ph.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues examined the associations of heavy metals with |
![]()
HealthDay
25 January at 04.47 PM
Denosumab Linked to Severe Hypocalcemia in Dialysis-Dependent SeniorsFor female dialysis-dependent patients aged 65 years or older treated for osteoporosis, denosumab is associated with an increased incidence of severe or very severe hypocalcemia, according to a study published online Jan. 19 in the Journal of the American Medical Association.Steven T. Bird, Ph.D., Pharm.D., from the U.S. Food and Drug |
![]()
HealthDay
11 January at 04.59 AM
Common Tools Suboptimal for ID'ing Fracture Risk in Younger Postmenopausal WomenThe Fracture Risk Assessment Tool (FRAX) and the Osteoporosis Self-assessment Tool (OST) have suboptimal performance for predicting 10-year major osteoporotic fracture risk across racial/ethnic categories in younger postmenopausal women; however, the OST has excellent discrimination for identifying osteoporosis, according to a study published online Ma |
![]()
HealthDay
28 December at 05.04 PM
Women With Osteoporosis Want to Know Their Fracture RiskMost women with osteoporosis want to know their fracture risk, but only half have received this information from health care providers, according to a study published online Nov. 13 in Osteoporosis International.Charlotte Beaudart, Ph.D., from Maastricht University in the Netherlands, and colleagues used data from the Risk Commun |
![]()
HealthDay
20 December at 11.11 PM
Osteoporosis Risk Increased With Long-Term Topical Corticosteroid ExposureThe risk for osteoporosis and major osteoporotic fracture (MOF) is increased in association with long-term exposure to topical corticosteroids (TCSs), according to a study published online Dec. 20 in the Journal of the European Academy of Dermatology and Venereology.Bing-Jun Hsieh, from the National Taiwan University Hospital in Taip |
![]()
HealthDay
13 December at 03.42 PM
Perfluorooctanesulfonic Acid Exposure Linked to Lower Bone DensityIn a cohort of Hispanic adolescents and young adults, plasma perfluorooctanesulfonic acid (PFOS) exposure is associated with lower bone mineral density (BMD), according to a study published online Dec. 6 in Environmental Research.Emily Beglarian, M.P.H., from the Keck School of Medicine at the University of Southern California in Los |
![]()
HealthDay
27 November at 10.55 PM
American College of Rheumatology, Nov. 10-15The annual meeting of the American College of Rheumatology was held this year from Nov. 10 to 15 in San Diego, and attendees included rheumatology specialists, physicians, scientists, and other health professionals. The conference featured presentations focusing on the latest advances in the diagnosis and treatment of arthritis as well as o |
![]()
Medical xPress
08 July at 06.16 AM
Scientists create first mouse model with complete, functional human immune systemA breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of mounting specific antibody responses. |
![]()
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
![]()
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |